1990至2016年帕金森病的全球、区域和国家疾病负担:2016年全球疾病负担研究的系统分析
该研究通过系统分析流行病学研究,估计1990至2016年帕金森病的全球、区域和国家患病率及残疾生存年数,并联合建模估计死亡与伤残调整生命年。年龄标化患病率较1990年上升21.7%。全球疾病负担在过去一代人中翻倍以上。
要点
- 1990至2016年年龄标化患病率上升21.7%(95%UI 18.1–25.3),粗患病率上升74.3%(69.2–79.6)。
核心结论
- 过去一代人中,由于老年人数增加、病程延长和环境因素等潜在贡献,全球帕金森病负担增加一倍以上。
- 人口学及其他潜在因素可能使未来帕金森病负担大幅增加。
研究设计与样本
- 通过系统分析流行病学研究,估计1990至2016年全球、区域和国家帕金森病患病率及残疾生存年数。
- 根据使用Hoehn和Yahr量表的研究估计轻、中、重度帕金森病比例,并为各等级分配残疾权重。
- 在自然史模型中联合建模患病率和超额死亡风险以估计帕金森病死亡,死亡数乘以全球疾病负担研究的标准预期寿命计算寿命损失年。
- 伤残调整生命年为残疾生存年数与寿命损失年之和,并按社会人口指数分析结果。
主要发现
- 1990至2016年年龄标化患病率上升21.7%(95%UI 18.1–25.3),粗患病率上升74.3%(95%UI 69.2–79.6)。
- 年龄标化患病率的男女比在2016年为1.40(95%UI 1.36–1.43),1990年为1.37(95%UI 1.34–1.40)。
- 1990至2016年,除南拉丁美洲、东欧和大洋洲外,所有全球疾病负担区域的年龄标化患病率、伤残调整生命年率和死亡率均上升;年龄标化伤残调整生命年率随社会人口指数总体上升。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neurological disorders are now the leading source of disability globally, and ageing is increasing the burden of neurodegenerative disorders, including Parkinson's disease. We aimed to determine the global burden of Parkinson's disease between 1990 and 2016 to identify trends and to enable appropriate public health, medical, and scientific responses. METHODS: Through a systematic analysis of epidemiological studies, we estimated global, regional, and country-specific prevalence and years of life lived with disability for Parkinson's disease from 1990 to 2016. We estimated the proportion of mild, moderate, and severe Parkinson's disease on the basis of studies that used the Hoehn and Yahr scale and assigned disability weights to each level. We jointly modelled prevalence and excess mortality risk in a natural history model to derive estimates of deaths due to Parkinson's disease. Death counts were multiplied by values from the Global Burden of Disease study's standard life expectancy to compute years of life lost. Disability-adjusted life-years (DALYs) were computed as the sum of years lived with disability and years of life lost. We also analysed results based on the Socio-demographic Index, a compound measure of income per capita, education, and fertility. FINDINGS: In 2016, 6·1 million (95% uncertainty interval [UI] 5·0-7·3) individuals had Parkinson's disease globally, compared with 2·5 million (2·0-3·0) in 1990. This increase was not solely due to increasing numbers of older people, because age-standardised prevalence rates increased by 21·7% (95% UI 18·1-25·3) over the same period (compared with an increase of 74·3%, 95% UI 69·2-79·6, for crude prevalence rates). Parkinson's disease caused 3·2 million (95% UI 2·6-4·0) DALYs and 211 296 deaths (95% UI 167 771-265 160) in 2016. The male-to-female ratios of age-standardised prevalence rates were similar in 2016 (1·40, 95% UI 1·36-1·43) and 1990 (1·37, 1·34-1·40). From 1990 to 2016, age-standardised prevalence, DALY rates, and death rates increased for all global burden of disease regions except for southern Latin America, eastern Europe, and Oceania. In addition, age-standardised DALY rates generally increased across the Socio-demographic Index. INTERPRETATION: Over the past generation, the global burden of Parkinson's disease has more than doubled as a result of increasing numbers of older people, with potential contributions from longer disease duration and environmental factors. Demographic and potentially other factors are poised to increase the future burden of Parkinson's disease substantially. FUNDING: Bill & Melinda Gates Foundation.
引用
- Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018. PMID: 30287051. doi:10.1016/S1474-4422(18)30295-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。